SI0929516T1 - Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect - Google Patents

Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect

Info

Publication number
SI0929516T1
SI0929516T1 SI9730439T SI9730439T SI0929516T1 SI 0929516 T1 SI0929516 T1 SI 0929516T1 SI 9730439 T SI9730439 T SI 9730439T SI 9730439 T SI9730439 T SI 9730439T SI 0929516 T1 SI0929516 T1 SI 0929516T1
Authority
SI
Slovenia
Prior art keywords
ltb4
medicaments
antagonistic effect
benzamidine derivatives
benzamidine
Prior art date
Application number
SI9730439T
Other languages
Slovenian (sl)
Inventor
Kurt Schromm
Ralf Anderskewitz
Ernst-Otto Renth
Franz Birke
Hans Michael Jennewein
Christopher John Montague Meade
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19636689A external-priority patent/DE19636689A1/en
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of SI0929516T1 publication Critical patent/SI0929516T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
SI9730439T 1996-09-10 1997-09-09 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect SI0929516T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19636689A DE19636689A1 (en) 1996-09-10 1996-09-10 New benzamidine derivatives
EP97942007A EP0929516B1 (en) 1996-09-10 1997-09-09 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
PCT/EP1997/004921 WO1998011062A1 (en) 1996-09-10 1997-09-09 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect

Publications (1)

Publication Number Publication Date
SI0929516T1 true SI0929516T1 (en) 2003-04-30

Family

ID=26029215

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730439T SI0929516T1 (en) 1996-09-10 1997-09-09 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect

Country Status (1)

Country Link
SI (1) SI0929516T1 (en)

Similar Documents

Publication Publication Date Title
HK1020564A1 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
IL128800A0 (en) 4-Heteroylpyrazol derivatives and the use thereof as herbicides
AU2766097A (en) Acyl mercapto-triazolyl derivatives and the use thereof as microbicides
HRP960365B1 (en) New medicaments and the use thereof
AU3577995A (en) Urea derivatives and their use as acat-inhibitors
HUP0102585A3 (en) Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments
HUP9902449A3 (en) Androstene derivatives, medicaments containing the same and their use
HK1105580A1 (en) Use of isoflavone compounds in the manufacture of medicament and composition comprising the same
PL348349A1 (en) Antrhranilic acid amides and the use thereof as medicaments
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
HUP9904335A3 (en) Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
GB2327675B (en) Nicotinamide derivatives and their use as medicaments
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
NZ332309A (en) Alkylamino-benzothiazole and -benzoxazole derivatives and medicaments
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
AU2841801A (en) Triazolotriazinones and the use thereof
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
AU3138595A (en) Haloperidol analogs and the use thereof
IL127518A0 (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
IL144525A0 (en) Benzamide derivatives and drugs containing the same
ZA986273B (en) Purine derivatives and the use for medicine thereof.
IL123535A0 (en) Benzoxazindione derivatives and their use